Bank of New York Mellon
ACHV icon

Bank of New York Mellon’s Achieve Life Sciences ACHV Stock Holding History

Bank of New York Mellon’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
+218,126
New +$1.04M ﹤0.01% 3153
2025
Q2 		– Sell
-80,357
Closed -$215K – 4138
2025
Q1 		$215K Buy
80,357
+2,585
+3% +$8.04K ﹤0.01% 3861
2024
Q4 		$274K Buy
77,772
+555
+0.7% +$2.52K ﹤0.01% 3827
2024
Q3 		$366K Sell
77,217
-25,338
-25% -$116K ﹤0.01% 3666
2024
Q2 		$482K Buy
+102,555
New +$494K ﹤0.01% 3603
2024
Q1 		– Sell
-11,441
Closed -$47.1K – 4152
2023
Q4 		$47.1K Hold
11,441
– – ﹤0.01% 4160
2023
Q3 		$49.2K Hold
11,441
– – ﹤0.01% 4163
2023
Q2 		$59.4K Sell
11,441
-231
-2% -$1.62K ﹤0.01% 4152
2023
Q1 		$79.4K Buy
+11,672
New +$55.5K ﹤0.01% 4110
2017
Q3 		– Sell
-29
Closed -$22K – 4263
2017
Q2 		$22K Buy
29
+4
+16% +$3.24K ﹤0.01% 4223
2017
Q1 		$24K Buy
25
+9
+56% +$10.9K ﹤0.01% 4218
2016
Q4 		$18K Sell
16
-1
-6% -$988 ﹤0.01% 4223
2016
Q3 		$19K Sell
17
-3
-15% -$4.78K ﹤0.01% 4220
2016
Q2 		$43K Hold
20
– – ﹤0.01% 4196
2016
Q1 		$30K Hold
20
– – ﹤0.01% 4140
2015
Q4 		$52K Hold
20
– – ﹤0.01% 4180
2015
Q3 		$96K Buy
20
+11
+122% +$66.3K ﹤0.01% 4123
2015
Q2 		$44K Buy
9
+1
+13% +$4.96K ﹤0.01% 4176
2015
Q1 		$37K Hold
8
– – ﹤0.01% 4161
2014
Q4 		$39K Hold
8
– – ﹤0.01% 4167
2014
Q3 		$46K Hold
8
– – ﹤0.01% 4146
2014
Q2 		$64K Sell
8
-21
-72% -$258K ﹤0.01% 4048
2014
Q1 		$755K Buy
29
+1
+4% +$24.6K ﹤0.01% 3416
2013
Q4 		$520K Hold
28
– – ﹤0.01% 3577
2013
Q3 		$562K Hold
28
– – ﹤0.01% 3476
2013
Q2 		$594K Buy
+28
New +$626K ﹤0.01% 3426

Other funds holding ACHV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Bank of New York Mellon's ACHV Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 218,126 shares worth $1.42M. The stake represents ﹤0.01% of the portfolio and ranks #3153 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in ACHV as recently as Q1 2025.

Bank of New York Mellon first reported a position in ACHV in Q2 2013 and has held it in 26 quarters since. 62 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Bank of New York Mellon held 218,126 shares of Achieve Life Sciences worth $1.42M as of Q2 2026.
  • Achieve Life Sciences was a new Bank of New York Mellon position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3153 holding.
  • Bank of New York Mellon first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 26 quarters since.
  • 62 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.